评论了期刊 2021-09-21

RADIOTHER ONCOL

投稿命中率:25.0
经验分享:撰写肿瘤分期,第三天显示under review,希望能顺利外审!

评论了期刊 2021-08-11

FRONT ONCOL

审稿速度:6.0 | 投稿命中率:50.0 | 影响因子:6.2
偏重的研究方向: 肿瘤
经验分享:历时最久一次投稿,期间审稿人2小修后突然退出审稿。 Date Updates 09 Aug 2021 Article accepted for publication. 07 Aug 2021 Review of Review Editor 3 finalized. 05 Aug 2021 You posted new comments. 30 Jul 2021 Review of Review Editor 1 finalized. 19 Jul 2021 You posted new comments. You posted new comments. Review Editor 2 posted new comments. Review Editor 2 posted new comments. 08 Jul 2021 Corresponding Author re-submitted manuscript. 29 Jun 2021 Interactive review forum activated. 14 Mar 2021 Corresponding Author

回复了评论 2021-07-24

J NATL COMPR CANC NE

2周左右被拒

评论了期刊 2021-07-01

J NATL COMPR CANC NE

双盲审稿,Received/Under Preliminary Consideration 6天没有动静

评论了期刊 2021-06-12

LIVER CANCER

再次第9天被拒。建议转投。

评论了期刊 2021-06-10

LIVER CANCER

投稿后第二天pre-evalued一周了,希望能送外审

评论了期刊 2021-03-01

HEPATOL INT

审稿速度:1.0 | 投稿命中率:25.0
经验分享:经过1个月大修,三个审稿人。小修终于接受,前后经历3个月。

评论了期刊 2021-02-28

RADIAT ONCOL

审稿速度:2.0 | 投稿命中率:25.0
经验分享:再中一篇,一审2个月,大修半个月,接受。虽然影响因子不高,但是放疗专业专刊,认可度较好。也不愿意投稿Frontiers in oncology

评论了期刊 2021-01-20

HEPATOL INT

审稿速度:1.0 | 投稿命中率:25.0
经验分享:肝癌放疗 投稿一月大修,期待好运

评论了期刊 2020-06-30

AGE

杂志是不是被踢了?

评论了期刊 2020-02-29

FRONT ONCOL

不是拉黑,是暂时取消版面费报销。185QbBy6749(暂无昵称) 2020-02-28 00:00:00 发表:
不给报销版面费是因为这个杂志被拉黑,还是因为最近的文件有关啊,不是说超过2w才需要审核吗

评论了期刊 2020-02-27

FRONT ONCOL

放疗板块,红皮二审被拒改投这杂志。期间2个审稿人,其中一个小修,一个大修(因为统计问题和表达问题提出非常专业的修改意见,返修6次,终于同意)。医院刚刚取消版面费报销,2490美金。Received date: 29 Oct 2019 Editorial assignment start date: 30 Oct 2019 Independent review start date: 18 Nov 2019 Interactive review activated date: 24 Dec 2019 Review finalized date: 25 Feb 2020 Final validation date: 27 Feb 2020

评论了期刊 2019-11-01

RADIOTHER ONCOL

Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?188****8186(暂无匿称) 2019-09-28 00:00:00 发表:
我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天

评论了期刊 2019-09-28

RADIOTHER ONCOL

我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天LLL123456789 2018-09-03 10:57:00 发表:
with editor 1个月,啥情况啊

评论了期刊 2019-06-21

CANCER SCI

应该有,4.751

共52条页码: 1/4页15条/页